Drug Approval | October 20, 2023
USFDA approves Pfizer’s Velsipity for adults with Ulcerative Colitis
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Alleviating staff shortages by empowering surgeons with greater personalization and control
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The generous donation includes multiple medical equipments
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Subscribe To Our Newsletter & Stay Updated
